bezuclastinib   Click here for help

GtoPdb Ligand ID: 11868

Synonyms: CGT-9486 | CGT9486 | PLX-9486 | PLX9486
PDB Ligand
Compound class: Synthetic organic
Comment: Bezuclastinib (CGT9486; formerly PLX-9486) is a KIT inhibitor that was designed for anti-tumour potential, particularly for tumours that carry KIT mutations that confer resistance to imatinib [1]. It has limited ability to cross the blood-brain-barrier, so is expected to have a low risk of central nervous system toxicity.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 86.46
Molecular weight 331.14
XLogP 4.11
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1n[nH]c(c1C)C)Nc1cnc2c(c1)cc([nH]2)c1ccccc1
Isomeric SMILES Cc1c([nH]nc1C(=O)Nc1cnc2c(c1)cc([nH]2)c1ccccc1)C
InChI InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24)
InChI Key NVSHVYGIYPBTEZ-UHFFFAOYSA-N
References
1. Gebreyohannes YK, Burton EA, Wozniak A, Matusow B, Habets G, Wellens J, Cornillie J, Lin J, Nespi M, Wu G et al.. (2019)
PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors.
Clin Exp Med, 19 (2): 201-210. [PMID:30523507]